DARWIN Biomed closes €1M pre-seed round for health robotics
DARWIN Biomed closed a €1 million pre-seed round to accelerate clinical validation of its advanced health-robotics technology.
Evidence notes
- Easo Ventures and Sodena led the financing as financial investors.
- ERREKA participated as an industrial partner.
- The round supports development and clinical validation of DARWIN Biomed technology for improving quality of life.
Company context
DARWIN Biomed develops MICHELANGELO, an assistive smart walker that combines sensors, motorized wheels and active fall-prevention logic for healthcare and mobility support.